Listing & Compliance Notices

LAVA Therapeutics NV received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“February 27, 2025, LAVA Therapeutics N.V. (the “Company”) received a notice from The Nasdaq Stock Market (“Nasdaq”) that the Company is not in compliance with Nasdaq’s Listing Rule 5450(a)(1), as the minimum bid price of the Company’s common shares has been below $1.00 per share for 30 consecutive business days. The notification of noncompliance has no immediate effect on the listing or trading of the Company’s common shares on The Nasdaq Global Select Market. The Company has 180 calendar days, or until August 26, 2025, to regain compliance with the minimum bid price requirement. To regain com”

Context Therapeutics Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“February 27, 2025, Context Therapeutics Inc. (the “Company”) received written notice (the “Notification Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”) because the Company’s common stock failed to maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days. The Notification Letter has no immediate effect on the Nasdaq listing or trading of the Company’s common stock. The Notification Letter provides an initial 180 calendar day period, or until Augu”

Century Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“February 26, 2025, Century Therapeutics, Inc. (the “Company”) received a notification letter (the “Bid Price Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 31 consecutive business days, the closing bid price for the Company’s common stock has been below the minimum $1.00 per share required for continued listing on The Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1) (“Rule 5450(a)(1)”). The Bid Price Letter is a notice of deficiency, not delisting, and does not currently affect the listing or trading of the Company’s shares o”

ECD Automotive Design, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

“February 25, 2025, ECD Automotive Design Inc., a Delaware corporation (the “Company”), received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”), stating that the Company’s common stock failed to maintain a minimum market value of listed securities (“MVLS”) of $35 million for the last 30 consecutive business days. Accordingly the Company failed to comply with Rule 5550(b)(2) of the Nasdaq Listing Rules (the “Rules”). The Notice has no immediate effect on the listing of the Company’s common stock on Nasdaq. Rule 5810(c)(3)(C) provides the Company a compliance period of 180 ca”

VERU INC. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“February 27, 2025, the Company received a notification (the “Extension Notice”) from Nasdaq informing the Company that Nasdaq has granted the Company an additional 180 calendar days, or until August 25, 2025, to regain compliance with the minimum closing bid price requirement under the Rule for continued listing on Nasdaq. The Extension Notice has no immediate effect on the listing of the Company’s common stock. In connection with its request for an extension, the Company stated that it intends to cure its bid price deficiency during such additional 180-day period, by effecting a reverse stock”

CURIS INC received a nasdaq noncompliance notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

“February 21, 2025, Curis, Inc. (the “Company”) received notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) that the Company was not in compliance with Nasdaq Listing Rule 5550(b)(2) (the “MVLS Requirement”), as the market value of the Company’s listed securities had been below $35,000,000 for the last 30 consecutive business days. The Notice indicated that Nasdaq Listing Rule 5810(c)(3)(C) provides the Company a compliance period of 180 calendar days, or until August 20, 2025 (the “Compliance Period”), to regain compliance with the MVLS R”

Bio Green Med Solution, Inc. received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).

“February 25, 2025, the Nasdaq Stock Market notified the Company that it has regained compliance with the equity requirement in Listing Rule 5550(b)(1) (the “Equity Rule”), as required by the Nasdaq Hearing Panel’s decision dated October 22, 2024. As previously reported by the Company on Form 8-K, filed with the Securities and Exchange Commission (the “SEC”) on October 24, 2024, on October 15, 2024, the Company met with the Nasdaq Hearings Panel regarding the Company’s potential delisting from The Nasdaq Stock Market as a result of its non-compliance with the Equity Rule. On October 22, 2024, t”

TECHPRECISION CORP received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“February 21, 2025, TechPrecision Corporation (the “ Company ”) received a notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “ Rule ”) because it had not timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024 (the “ Form 10-Q ”) with the Securities and Exchange Commission (the “ SEC ”) on or before February 19, 2025, the extended period provided for the filing under Rule 12b-25(b) of the Securities Exchange Act”

Energous Corp received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“February 27, 2025, Energous Corporation d/b/a Energous Wireless Power Solutions (the “Company”) received a letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) granting the Company an additional 180 calendar days, or until August 25, 2025, to regain compliance with the $1.00 per share minimum bid price requirement required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Marketplace Rule 5550(a)(2) (the “Bid Price Rule”). As previously reported, on August 29, 2024, the Company received a notification letter from the Staf”

Lulu's Fashion Lounge Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“February 27, 2025, Lulu’s Fashion Lounge Holdings, Inc. (“the Company”) received a letter from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive trading days, the bid price of the Company’s common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq listing rule 5450(a)(1). The notification received has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq. In accordance with listing rule 5810(c)(3)(A)”

Li-Cycle Holdings Corp. received a nyse delisting notice notice regarding minimum bid price (rules 802.01C).

“February 26, 2025, the Company received written notice (the “ Notice ”) from the New York Stock Exchange (the “ NYSE ”) indicating that it has determined to commence proceedings to delist the Common Shares as a result of the Company being not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Common Shares was less than $1.00 over a consecutive 30 trading-day period and the Company had effected a reverse stock split over the prior one-year period. Trading in the Common Shares on the NYSE was suspended immediately after market close on”

Healthcare Triangle, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“February 26, 2025, Healthcare Triangle, Inc. (the “ Company ”) received written notice (the “ Bid Price Notice ”) from the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that for the last 30 consecutive business days prior to the date of the Bid Price Notice, the closing bid price of the Company’s common stock was less than the $1.00 per share minimum bid price required for continued listing on The Nasdaq Capital Market, as required by Nasdaq Listing Rule 5550(a)(2) (the “ Bid Price Rule ”). In accordance with Nasdaq Listing”

Solo Brands, Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

“February 25, 2025, Solo Brands, Inc. (the “Company”) was notified by the New York Stock Exchange (the “NYSE”) that the average closing price of the Company’s Class A common stock, par value $0.001 per share, over the prior consecutive 30 trading-day period was below $1.00, which is the minimum average closing price required to maintain listing on the NYSE under Section 802.01C of the NYSE Listed Company Manual. Pursuant to Section 802.01C, the Company has a period of six months following receipt of the NYSE notice to regain compliance with the minimum share price requirement. In order to regai”

GRAPHJET TECHNOLOGY received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“February 21, 2025, Graphjet Technology, an exempted Cayman Islands company (the “ Company ”), received written notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) indicating that the Company no longer complies with Nasdaq Listing Rule 5550(a)(2) (the “ Rule ”) requiring that listed securities maintain a minimum bid price of $1 per share (the “ Minimum Bid Price ”) based upon the Company’s closing bid price for the last 32 consecutive days. Additionally, the Notice confirms that the Rule grants the Company 180 calendar days, or until August”

Lakeside Holding Ltd received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“February 21, 2025, Lakeside Holding Limited (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market, under Listing Rule 5550(b)(1), because the Company’s stockholders’ equity of $1,646,281 as reported in the Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2024 was below the required minimum of $2.5 million, and because, as of February 20, 2025”

Forward Industries, Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).

“February 21, 2025, Forward Industries, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) stating that Nasdaq has determined to delist the Company’s securities from The Nasdaq Capital Market. The determination was based on the Company’s failure to comply with Nasdaq Listing Rule 5550(b)(1), which requires a minimum of $2.5 million stockholders’ equity for continued listing. The Company recently filed its Form 10-Q for the quarter ended December 31, 2024 disclosing a stockholders’ equity of $2,279,297. Nasdaq has indicated that trading in the Company’s securities”

Super Micro Computer, Inc. received a nasdaq compliance regained notice regarding late filing (rules 5250(c)(1)).

“February 25, 2025, the Company received a notification letter from Nasdaq indicating that the Company now complies with Nasdaq listing rule 5250(c)(1) which requires timely filing of reports with the U.S. Securities and Exchange Commission (the “ SEC ”) and the matter is now closed. Prior to its filing on February 25, 2025, the Company had received a notification letter from Nasdaq on February 21, 2025, stating that the Company was not in compliance with Nasdaq listing rule 5250(c)(1) as a result of the Company’s delay in filing its Q2 FY2025 Form 10-Q and its continued delay in filing its FY2”

Outset Medical, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“February 24, 2025, the Company received a second notice (the “Notice”) from Nasdaq of failure to comply with the minimum bid price requirement. The Notice has no immediate effect on the listing of the Company’s common stock on the Nasdaq Global Select Market, which will continue to trade on the Nasdaq Global Select Market. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial compliance period of 180 calendar days, or until August 25, 2025, to regain compliance with the minimum bid price requirement. To regain compliance, the closing bid price of the Company’s”

CytomX Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“5 and February 21, 2025 the Company’s common stock, $0.00001 par value per share (the “Common Stock”), had not maintained a minimum bid price of $1.00 per share, required for continued listing on the Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). The Notice has no immediate effect on the listing of the Company’s common stock.”

Acurx Pharmaceuticals, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“February 24, 2025, Acurx Pharmaceuticals, Inc. (the “Company”) received a letter from The Nasdaq Stock Market (“Nasdaq”) notifying the Company that for the preceding 31 consecutive business days the Company’s common stock did not maintain a minimum closing bid price of $1.00 per share as required by Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The notice has no immediate effect on the listing or trading of the Company’s common stock, and the common stock will continue to trade on The Nasdaq Capital Market under the symbol “ACXP” at this time. In accordance with Nasdaq”

Aeries Technology, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“February 20, 2025, Aeries Technology, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the 30 consecutive business days from December 31, 2024 to February 19, 2025, the Company’s Class A ordinary shares had not maintained a minimum closing bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). The Notice does not impact the listing of the Company’s Clas”

REPUBLIC AIRWAYS HOLDINGS INC. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“or the “Initial Delinquent Filing”), as first reported in that notification letter (the “Initial Notice”) issued by the Nasdaq to the Company on January 15, 2025 (the “Initial Notice Date”), the Company is still not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”). The filing delay is not the result of a forthcoming restatement of the Company’s financial statements or any disagreement with the Company’s auditors. The New Notice has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital”

Outdoor Holding Co received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“February 19, 2025, the Company received an additional deficiency notification letter (the “ Notice ”) from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“ Nasdaq ”). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “ Listing Rule ”) as a result of the Company’s failure to timely file its Quarterly Report on Form 10-Q for the quarter ended December 31, 2024 (the “ Form 10-Q ”), as described more fully in the Company’s Form 12b-25 Notification of Late Filing filed with the Securities and Exchange Commission (the “ SEC ”) on F”

Flux Power Holdings, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“ecember 31, 2024 (the “December Form 10-Q”) and because the Company remains delinquent in filing its Form 10-Q for the period ended September 30, 2024 (the “September Form 10-Q” and together with the December Form 10-Q, the “Delinquent Reports”), the Company does not comply with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires Nasdaq-listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission. The Notice states that as a result of this additional delinquency, the Company must submit an update to its original plan to reg”

BRC Group Holdings, Inc. received a nasdaq compliance regained notice regarding late filing (rules 5250(c)(1)).

“February 24, 2025, the Company received a notice from Nasdaq indicating that, based on the Company’s filing of the Third Quarter 10-Q, the Company is in compliance with the Rule and the matter is now closed. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. B. Riley Financial, Inc. By: /s/Phillip Ahn Name: Phillip Ahn Title: CFO & COO Date: February 25, 2025”

Rallybio Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“February 24, 2025, Rallybio Corporation (the “Company” or “Rallybio”) received a notification letter from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the closing bid price of the Company’s shares of common stock was below the minimum closing bid price of $1.00 per share during the last 30 consecutive business days (the “Notice”), as required for continued listing on the Nasdaq under Rule 5450(a)(1) of the Nasdaq’s Listing Rules (the “Rules”). The Notice has no immediate impact on the listing of the Company’s common stock, wh”

CEMTREX INC received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“February 21, 2025, Cemtrex, Inc. (the “Company”) received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the stockholder’s equity for the Company was below $2,500,000 as reported on our Form 10-Q for the period ended December 31, 2024, the Company no longer meets the minimum shareholder’s equity requirement for continued listing on The Nasdaq Capital Market under Nasdaq Marketplace Rule 5550(b)(1), requiring a minimum stockholder’s equity of $2,500,000 (the “Minimum Stockholder’s Equity Requirement””

ATOSSA THERAPEUTICS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“February 21, 2025, Atossa Therapeutics, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq, because the Company's common stock failed to maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days. The Company has until August 20, 2025 to regain compliance with Nasdaq Listing Rule 5550(a)(2). In the event the Company does not regain compliance by then, the Company may b”

CIMG Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“February 19, 2025, CIMG Inc. (the “Company”) received a notification letter (the “Periodic Report Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Listing Rule 5250(c)(1) because the Company did not timely file its quarterly report on Form 10-Q for the period ended December 31, 2024 with the Securities and Exchange Commission (the “SEC”). The Periodic Report Notice has no immediate effect on the listing of the Company’s common stock on Nasdaq. In accordance with the earlier deficiency notice lett”

American Resources Corp received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2)).

“February 19, 2025, American Resources Corporation (or the “Company”) received a letter from the Nasdaq Stock Market indicating that for 30 consecutive business days the Company’s stock has not maintained a minimum closing bid price of $1.00 per share (“Minimum Bid Price Requirement”) as required by Nasdaq Listing Rule 5550(a)(2). The notification of noncompliance has no immediate effect on the listing or trading of the Company’s stock on the Nasdaq Capital Market. Under the Listing Rules, if during the 180 calendar days following the date of the notification, or prior to August 18, 2025, the”

Anebulo Pharmaceuticals, Inc. received a nasdaq extension granted notice regarding shareholders (rules 5635(b)).

“February 24, 2025, the Company received a letter from Nasdaq notifying it that based on the Compliance Plan submitted to Nasdaq, the Nasdaq Staff has determined to grant the Company an extension to regain compliance with Rule 5635(b), as described below. The Compliance Plan proposed that 22NW and the Company enter into an irrevocable lock-up agreement pursuant to which 22NW would agree not to vote, sell, transfer, pledge or otherwise dispose of the Shares until such time as the Company obtained stockholder approval of the removal of such restrictions. In addition, irrevocable instructions to t”

Anebulo Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding shareholders (rules 5635(b)).

“February 20, 2025, the Company received a letter (the “Letter”) from The Nasdaq Stock Market (“Nasdaq”) stating that the Company failed to comply with Nasdaq Listing Rule 5635(b) (“Rule 5635(b)”), which requires stockholder approval prior to the issuance of securities when the issuance or potential issuance will result in a change of control of the Company. Prior to the Private Placement, the Company had two directors, Joseph F. Lawler and Aron English, that each beneficially owned in excess of 40% of the Company’s outstanding shares of Common Stock; however immediately after consummation of t”

SOCIETY PASS INCORPORATED. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(2)).

“February 18, 2025, Society Pass Incorporated (the “Company”) received written notice (the “Delist Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the Company’s continued non-compliance with Rule 5550(b)(2) which requires that the Company shall maintain at least $2,500,000 stockholders’ equity, the Nasdaq staff has determined to delist the Company’s common stock from the Nasdaq Capital Market effective February 27, 2025 unless the Company timely requests an appeal of this determination before the Nasdaq Hearings Panel (the “Panel”) by February 25, 2025. The Comp”

Omega Therapeutics, Inc. received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1, 5450(a)(1)).

“February 18, 2025, Company received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that Nasdaq had determined to delist the Company’s common stock, par value $0.001 per share (the “Common Stock”). Nasdaq reached its decision that the Company is no longer suitable for listing pursuant to Nasdaq Listing Rules 5101, 5110(b), and IM-5101-1 as a result of the Company’s commencement of the Chapter 11 Case on February 10, 2025. The Notice also indicated that concerns about the Company’s ability to sustain compli”

FORMATION MINERALS, INC. received a otc deficiency notice notice regarding late filing (rules 15C-211).

“February 18, 2025. On February 18, 2025, the Company filed the 10-Q, which removed the company from the expert market and moved it to the OTC Pink market. The company has filed an application with OTC to move back up to the OTCQB Tier. Along with that application, OTC Markets will be handling the form 15c-211 which will bring the company back into full compliance within approximately the next 30 days. 1 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized”

Greenland Mines Ltd received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(A)).

“February 14, 2025, the Company received written notice (the “Delisting Notice”) from the Nasdaq Listing Qualifications Department stating that the Company has not regained compliance with the Rules and the Company’s securities will be delisted from The Nasdaq Global Markets (the “Delisting Determination”) unless the Company requests an appeal of this determination by February 21, 2025 pursuant to procedures set forth in Nasdaq Listing Rule 5800 Series. On February 21, 2025, the Company exercised its right to request a hearing to appeal the Delisting Determination and paid Nasdaq the applicable”

Greenland Mines Ltd received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(C)).

“February 14, 2025, the Company received written notice (the “Delisting Notice”) from the Nasdaq Listing Qualifications Department stating that the Company has not regained compliance with the Rules and the Company’s securities will be delisted from The Nasdaq Global Markets (the “Delisting Determination”) unless the Company requests an appeal of this determination by February 21, 2025 pursuant to procedures set forth in Nasdaq Listing Rule 5800 Series. On February 21, 2025, the Company exercised its right to request a hearing to appeal the Delisting Determination and paid Nasdaq the applicable”

Global Star Acquisition Inc. received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(A), 5810(c)(3)(C), 5450(b)(1), 5450(b)(3), 5450(b)(2)(B), 5450(a)(2)).

“February 19, 2025, the Company received a notice from the Staff that the Company did not comply with the MVLS Requirement by the Compliance Date, and that the matter will serve as an additional basis for delisting the Company’s securities from Nasdaq. The Company was also notified that it does not meet the continued listing requirements under Listing Rule 5450(b)(1) (the “Equity Standard”) or Listing Rule 5450(b)(3) (the “Total Assets/Total Revenue Standard”) requirements. Pursuant to Listing Rule 5810(d), the Company will present its views to the Hearings Panel (the “Panel”) at a hearing sche”

Rain Enhancement Technologies Holdco, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C)).

“February 18, 2025, Rain Enhancement Technologies Holdco, Inc. (the “Company”) received written notice (the “MVLS Notice”) from the Listing Qualifications Staff (“Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) which notified the Company that, for the 30 consecutive business days ended February 14, 2025, the Company’s market value of listed securities (“MVLS”) closed below the $50,000,000 MVLS threshold required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has 180”

Rain Enhancement Technologies Holdco, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

“February 18, 2025, Rain Enhancement Technologies Holdco, Inc. (the “Company”) received written notice (the “MVLS Notice”) from the Listing Qualifications Staff (“Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) which notified the Company that, for the 30 consecutive business days ended February 14, 2025, the Company’s market value of listed securities (“MVLS”) closed below the $50,000,000 MVLS threshold required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has 180”

LIXTE BIOTECHNOLOGY HOLDINGS, INC. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)).

“om the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) on August 19, 2024 indicating that the Company was not in compliance with the minimum stockholders’ equity requirement of $2,500,000 for continued listing on the Nasdaq Capital Market under Listing Rule 5550(b) (the “Stockholders’ Equity Requirement”). On October 3, 2024, the Company submitted a plan to the Staff to regain compliance with the Stockholders’ Equity Requirement, which outlined the Company’s proposed initiatives to regain compliance by raising equity capital through various registered”

AMERICAN REBEL HOLDINGS INC received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“February 19, 2025, the Company received a letter (the “Notification Letter”) from The Nasdaq Stock Market (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5550(b)(1) (the “Rule”) because the stockholders’ equity of the Company as of September 30, 2024, as reported in the Company’s Quarterly Report on Form 10-Q filed with the SEC on February 7, 2025, was below the minimum requirement of $2,500,000 (the “Stockholders’ Equity Requirement”). As of the date of this Current Report on Form 8-K, the Company does not meet the alternative quantitative standards for cont”

Nikola Corp received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1).

“February 19, 2025, filed voluntary petitions for relief under chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Filing”). On February 19, 2025, the Company received a letter (the “Delisting Notice”) from the staff of the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Staff had determined that the Company’s securities will be delisted from Nasdaq pursuant to Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1. Pursuant to the Delisting”

ChargePoint Holdings, Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

“February 19, 2025, ChargePoint Holdings, Inc. (the “Company”) was notified by the New York Stock Exchange (the “NYSE”) that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s Common Stock ("the Common Stock") was less than $1.00 over a consecutive 30 trading-day period. The notice does not result in the immediate delisting of the Company’s Common Stock from the NYSE. The Company plans to notify the NYSE by March 5, 2025 that it intends to cure the average closing stock price deficiency and to return to compliance wi”

FutureTech II Acquisition Corp. received a nasdaq deficiency notice notice regarding other (rules IM-5101-2).

“February 19, 2025 from the Nasdaq Stock Market LLC (“Nasdaq”), stating that the Company did not comply with Nasdaq Interpretive Material IM-5101-2, and that its securities are now subject to delisting. The Company’s registration statement, filed in connection with the Company’s IPO, became effective February 14, 2022. Pursuant to IM-5101-2, the Company, a special purpose acquisition company, must complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement. Since the Company did not complete its initial business combination by February 14”

iCoreConnect Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)).

“February 17, 2025 to regain compliance with the Equity Rule, and, as of such date, the Company was not in compliance with the Equity Rule. On February 18, 2025, the Company was notified by the Staff that unless the Company requests an appeal of the Staff’s determination by February 25, 2025, trading of the Company’s common stock will be suspended at the opening of business on February 27, 2025, and a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove the Company’s securities from listing and registration on The Nasdaq Stock Market. The Company plans to tim”

Spire Global, Inc. received a nyse extension granted notice regarding late filing (rules 802.01E).

“February 18, 2025, Spire Global, Inc. (the “Company”) received written notice from the New York Stock Exchange (the “NYSE”) that it has provided the Company with an extension through April 15, 2025 to complete and file the Company’s Quarterly Reports on Form 10-Q for the quarters ended June 30, 2024 and September 30, 2024 with the Securities and Exchange Commission (the “SEC”). As previously disclosed, on August 21, 2024, the Company received written notice from the NYSE that the Company was not in compliance with Section 802.01E of the NYSE Listed Company Manual due to the Company’s failure t”

CDT Equity Inc. received a nasdaq deficiency notice notice regarding market value (rules 5810(d)(2)).

“February 12, 2025, Nasdaq informed the Company that the Staff had determined that the Company had not regained compliance with such requirements and as a result, pursuant to Nasdaq Listing Rule 5810(d)(2), these deficiencies now become additional bases for delisting the Company’s securities from the Nasdaq Global Market. The Company has already addressed these concerns before the Nasdaq Hearings Panel, although there can no assurance it will be permitted to implement its plan of compliance and ultimately regain compliance and remain listed on any Nasdaq Market.”

BIO-PATH HOLDINGS, INC. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).

“February 14, 2025, the Nasdaq Stock Market LLC (“Nasdaq”) notified Bio-Path Holdings, Inc. (the “Company”) that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s common stock, par value $0.001 per share (“Common Stock”), and that trading of the Company’s Common Stock will be suspended at the open of trading on February 19, 2025. ​ As previously reported, on November 19, 2024, the Company was granted an extension until January 31, 2025 from the Panel to demonstrate compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed issuers to maintain minimum stoc”

RenX Enterprises Corp. received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).

“February 14, 2025, Safe and Green Development Corporation (the “Company”) received a letter from The Nasdaq Stock Market (“Nasdaq”) stating that based on the Company’s Form 8-K, as filed with the Securities and Exchange Commission on February 12, 2025, Nasdaq has determined that the Company now complies with the stockholders’ equity requirement as set forth in Nasdaq Listing Rule 5550(b)(1). As previously reported, on August 26, 2024, the Company had received a letter from Nasdaq stating that the Company did not comply with the minimum $2.5 million stockholders’ equity, $35 million market valu”